Oruka Therapeutics
ORKA
12 hedge funds and large institutions have $562K invested in Oruka Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
0% more funds holding
Funds holding: 12 → 12 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.05% less ownership
Funds ownership: 1.11% → 1.06% (-0.05%)
53% less capital invested
Capital invested by funds: $1.2M → $562K (-$642K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$50.2K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.61K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$2.33K |
| 4 |
CFN
Cordasco Financial Network
Naples,
Florida
|
+$109 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$54 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$55K |
| 2 |
Renaissance Technologies
New York
|
-$42K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$13.7K |
| 4 |
Morgan Stanley
New York
|
-$489 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $372K | -$42K | -773 | -7% |
|
|
TCM
2
Tekla Capital Management
Boston,
Massachusetts
| $100K | – | – | – |
|
|
3
Acadian Asset Management
Boston,
Massachusetts
| $80K | +$50.2K | +925 | +64% |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $8K | +$2.61K | +48 | +26% |
|
|
5
Victory Capital Management
San Antonio,
Texas
| $2K | +$2.33K | +43 | New |
|
|
6
JP Morgan Chase
New York
| – | -$55K | -807 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$13.7K | -252 | -99% |
|
|
8
Morgan Stanley
New York
| – | -$489 | -9 | Closed |
|
|
9
Wells Fargo
San Francisco,
California
| – | +$54 | +1 | New |
|
|
CFN
10
Cordasco Financial Network
Naples,
Florida
| – | +$109 | +2 | New |
|
11
Osaic Holdings
Scottsdale,
Arizona
| – | +$272 | +5 | New |
|
ORKA Hedge Fund Activity: Q1 2020 in Review
12 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Oruka Therapeutics (ORKA) for Q1 2020, worth a combined $562K — down 53% from $1.2M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ORKA positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $50.2K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $55K sold.
- 12 institutional investors held Oruka Therapeutics (ORKA) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $562K of Oruka Therapeutics stock for Q1 2020, down 53% quarter-over-quarter.
- 4 funds opened new Oruka Therapeutics positions in Q1 2020 and 3 closed out, a net change of +1 holder.
- The largest Oruka Therapeutics buyer in Q1 2020 was Acadian Asset Management, an estimated $50.2K added.
- The largest Oruka Therapeutics seller in Q1 2020 was JP Morgan Chase, an estimated $55K sold.
Based on aggregated 13F filings for Q1 2020.